Report for Newton RS

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis development - Voros_2022_Front.Cardiovasc.Med_9_960419
Author(s) : Voros S , Bansal AT , Barnes MR , Narula J , Maurovich-Horvat P , Vazquez G , Marvasty IB , Brown BO , Voros ID , Harris W , Voros V , Dayspring T , Neff D , Greenfield A , Furchtgott L , Church B , Runge K , Khalil I , Hayete B , Lucero D , Remaley AT , Newton RS
Ref : Front Cardiovasc Med , 9 :960419 , 2022
Abstract : Voros_2022_Front.Cardiovasc.Med_9_960419
ESTHER : Voros_2022_Front.Cardiovasc.Med_9_960419
PubMedSearch : Voros_2022_Front.Cardiovasc.Med_9_960419
PubMedID: 36684605

Title : Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants - Aviram_1999_Free.Radic.Biol.Med_26_892
Author(s) : Aviram M , Rosenblat M , Billecke S , Erogul J , Sorenson R , Bisgaier CL , Newton RS , La Du BN
Ref : Free Radic Biol Med , 26 :892 , 1999
Abstract : Aviram_1999_Free.Radic.Biol.Med_26_892
ESTHER : Aviram_1999_Free.Radic.Biol.Med_26_892
PubMedSearch : Aviram_1999_Free.Radic.Biol.Med_26_892
PubMedID: 10232833

Title : Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation - Aviram_1998_Atherosclerosis_138_271
Author(s) : Aviram M , Rosenblat M , Bisgaier CL , Newton RS
Ref : Atherosclerosis , 138 :271 , 1998
Abstract : Aviram_1998_Atherosclerosis_138_271
ESTHER : Aviram_1998_Atherosclerosis_138_271
PubMedSearch : Aviram_1998_Atherosclerosis_138_271
PubMedID: 9690910

Title : Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase - Aviram_1998_J.Clin.Invest_101_1581
Author(s) : Aviram M , Rosenblat M , Bisgaier CL , Newton RS , Primo-Parmo SL , La Du BN
Ref : J Clinical Investigation , 101 :1581 , 1998
Abstract : Aviram_1998_J.Clin.Invest_101_1581
ESTHER : Aviram_1998_J.Clin.Invest_101_1581
PubMedSearch : Aviram_1998_J.Clin.Invest_101_1581
PubMedID: 9541487